日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Concomitant medication use and clinical outcome in hepatocellular carcinoma treated with immune-based therapy: a multicenter analysis

免疫疗法治疗肝细胞癌患者的合并用药与临床结局：一项多中心分析

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1680015
Yi, Jun-Zhe; Xu, Jie; Zeng, Jiang-Zheng; Song, Yu-Jia; Zhang, Yu-Nan; Huang, Cheng-Mou; Li, Lei; Ding, Ke; Zhu, Zhi-Jian; Yuan, Dao-Zu; Fan, Yu-Wen; Ning, Shang-Fu; Liu, Xin; Zhang, Jian-Zhong; You, Yong-Fei; Zhou, Qi; Song, Hao-Jie; Tan, Gen-Jun; Wu, Xin-Tong; Guo, Rong-Ping; Chen, Min-Shan; Lyu, Ning; Zhao, Ming
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis

动脉FOLFOX化疗联合抗PD-(L)1免疫疗法一线治疗不可切除肝内胆管癌的疗效和安全性：倾向评分匹配分析

期刊:Journal of Gastrointestinal Oncology
影响因子:2
doi:10.21037/jgo-24-552
Hu, Yue; Jiang, Xiong-Ying; Cai, Xi; Chen, Song; Chen, Qi-Feng; Yi, Jun-Zhe; Zhong, Sui-Xing; Wang, Jiong-Liang; Xu, Jie; Tan, Gen-Jun; Lyu, Ning; Zhao, Ming
肿瘤
胆管癌
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Study on substrate specificity at subsites for severe acute respiratory syndrome coronavirus 3CL protease

严重急性呼吸综合征冠状病毒3CL蛋白酶亚位点底物特异性的研究

期刊:Acta Biochimica et Biophysica Sinica
影响因子:3.4
doi:10.1111/j.1745-7270.2005.00114.x
Shan, Yu-Fei; Xu, Gen-Jun
微生物学
发表日期：2005
文献求助 收藏

A novel auto-cleavage assay for studying mutational effects on the active site of severe acute respiratory syndrome coronavirus 3C-like protease

一种用于研究突变对严重急性呼吸综合征冠状病毒3C样蛋白酶活性位点影响的新型自切割分析方法

期刊:Biochemical and Biophysical Research Communications
影响因子:2.2
doi:10.1016/j.bbrc.2004.09.088
Shan, Yu-Fei; Li, Shou-Feng; Xu, Gen-Jun
微生物学
发表日期：2004
文献求助 收藏